# NFIX

## Overview
The NFIX gene encodes the nuclear factor I X protein, a transcription factor belonging to the Nuclear Factor I (NFI) family. This protein is characterized by its conserved N-terminal DNA-binding and dimerization domain, which is essential for its role in regulating gene expression. The NFIX protein is involved in various biological processes, including neural development, hematopoiesis, and myogenesis, by influencing the differentiation and maturation of specific cell types. It can form both homodimers and heterodimers with other NFI family members, contributing to its functional diversity. Additionally, NFIX interacts with other proteins and nucleic acids to form multiprotein complexes that modulate gene expression. Mutations in the NFIX gene are linked to several syndromes, such as Malan syndrome, Sotos-like syndrome, and Marshall-Smith syndrome, underscoring its significance in human development and disease (Piper2019Nuclear; Driller2007Nuclear; Klaassens2014Malan).

## Structure
The NFIX protein is a member of the Nuclear Factor I (NFI) family, characterized by a conserved N-terminal DNA-binding and dimerization domain. This domain is crucial for its function in binding to specific DNA sequences, allowing NFIX to act as a transcriptional regulator (Singh2009A; Driller2007Nuclear). The DNA-binding domain is highly conserved across species, indicating its essential role in the protein's function (Fletcher1999Exon).

The C-terminal region of NFIX is involved in transactivation and repression, and it exhibits high variability due to extensive alternative splicing, resulting in multiple isoforms (Driller2007Nuclear). These isoforms can affect the protein's functional properties and its role in various biological processes (Singh2009A).

NFIX can form both homodimers and heterodimers with other NFI family members, adding to its structural and functional diversity (Kruse1994Transcription). The protein may also undergo post-translational modifications, such as tyrosine phosphorylation, which can influence its intracellular localization and interaction with other proteins, particularly in the context of growth factor signaling (Singh2009A).

## Function
The NFIX gene encodes a transcription factor that plays a crucial role in various biological processes in healthy human cells, particularly in neural development, hematopoiesis, and myogenesis. In neural development, NFIX is involved in the differentiation of neural stem cells and the generation of intermediate progenitor cells, promoting astrocyte-specific gene expression while repressing oligodendrocyte formation (Piper2019Nuclear). It is essential for the maturation and survival of neuroblasts in the hippocampus, driving neuronal differentiation and preventing unwanted oligodendrocytic differentiation (Harris2018Neurogenic).

In hematopoiesis, NFIX is highly expressed in hematopoietic stem and progenitor cells, regulating the expression of survival markers and influencing lineage commitment and survival, affecting both myeloid and lymphoid cell differentiation (Piper2019Nuclear). In myogenesis, NFIX is critical for the transition from embryonic to fetal muscle development, regulating the expression of fetal muscle-specific genes and inhibiting embryonic genes (Piper2019Nuclear).

NFIX is also involved in maintaining the quiescent state of neural stem cells by influencing the expression of extracellular matrix and cell adhesion molecules, which are crucial for stem cell adhesion to their niche (Martynoga2013Epigenomic).

## Clinical Significance
Mutations in the NFIX gene are associated with several distinct syndromes, primarily Malan syndrome, Sotos-like syndrome, and Marshall-Smith syndrome. Malan syndrome is characterized by overgrowth, macrocephaly, developmental delay, and specific facial features. It is linked to whole gene deletions, nonsense variants, and missense variants affecting the DNA-binding domain of NFIX (Oishi2019Heterozygosity; Klaassens2014Malan). 

Sotos-like syndrome, which shares features with Sotos syndrome but lacks the facial gestalt, is associated with NFIX mutations, particularly in the DNA-binding/dimerization domain. These mutations result in haploinsufficiency, leading to overgrowth, advanced bone age, and macrocephaly (Yoneda2012Missense; Martinez2015Novel). 

Marshall-Smith syndrome is a more severe condition characterized by accelerated skeletal maturation, respiratory difficulties, and intellectual disability. It is caused by frameshift and splice-site mutations in NFIX that often escape nonsense-mediated mRNA decay, resulting in a dominant-negative effect (Malan2010Distinct; Martinez2015Novel). 

NFIX mutations can lead to different phenotypes depending on their impact on mRNA decay and protein function, highlighting the gene's critical role in development (Malan2010Distinct).

## Interactions
NFIX, a transcription factor, engages in various interactions with other proteins and nucleic acids, forming multiprotein complexes that regulate gene expression. NFIX interacts with CGGBP1 and HMGN1 to form a transcriptional complex that regulates the transcription of HSF1. This interaction is sensitive to heat shock conditions, with CGGBP1 playing a central role in organizing the complex at the HSF1 promoter (Singh2009A). NFIX's binding to the HSF1 promoter is dependent on CGGBP1 and HMGN1, although CGGBP1 can bind independently (Singh2009A).

In the context of prostate-specific gene expression, NFIX interacts with the androgen receptor (AR) and FOXA1. FOXA1 acts as a bridge, facilitating the interaction between NFIX and AR, which is crucial for regulating AR-target genes (Grabowska2014NFI). NFIX, along with other NFI family members, can bind to AR-target gene promoters, influencing gene expression (Grabowska2014NFI).

NFIX also interacts with LEF1 in the regulation of quiescence in adult hippocampal neural stem and progenitor cells. This interaction is part of a molecular program that transitions cells from proliferation to quiescence (GarcíaCorzo2022The). These interactions highlight NFIX's role in diverse biological processes through its ability to form complexes with various proteins.


## References


[1. (Singh2009A) Umashankar Singh, Erik Bongcam-Rudloff, and Bengt Westermark. A dna sequence directed mutual transcription regulation of hsf1 and nfix involves novel heat sensitive protein interactions. PLoS ONE, 4(4):e5050, April 2009. URL: http://dx.doi.org/10.1371/journal.pone.0005050, doi:10.1371/journal.pone.0005050. This article has 25 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0005050)

[2. (Kruse1994Transcription) Ulrich Kruse and Albrecht E. Sippel. Transcription factor nuclear factor i proteins form stable homo‐ and heterodimers. FEBS Letters, 348(1):46–50, July 1994. URL: http://dx.doi.org/10.1016/0014-5793(94)00585-0, doi:10.1016/0014-5793(94)00585-0. This article has 94 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/0014-5793(94)00585-0)

[3. (Grabowska2014NFI) Magdalena M. Grabowska, Amicia D. Elliott, David J. DeGraff, Philip D. Anderson, Govindaraj Anumanthan, Hironobu Yamashita, Qian Sun, David B. Friedman, David L. Hachey, Xiuping Yu, Jonathan H. Sheehan, Jung-Mo Ahn, Ganesh V. Raj, David W. Piston, Richard M. Gronostajski, and Robert J. Matusik. Nfi transcription factors interact with foxa1 to regulate prostate-specific gene expression. Molecular Endocrinology, 28(6):949–964, June 2014. URL: http://dx.doi.org/10.1210/me.2013-1213, doi:10.1210/me.2013-1213. This article has 70 citations.](https://doi.org/10.1210/me.2013-1213)

[4. (Fletcher1999Exon) Colin F. Fletcher, Nancy A. Jenkins, Neal G. Copeland, Ali Z. Chaudhry, and Richard M. Gronostajski. Exon structure of the nuclear factor i dna-binding domain from c. elegans to mammals nfia ), af111264 ( nfib ), af111265 ( nfic ), af111266 ( nfix ).–&gt;. Mammalian Genome, 10(4):390–396, April 1999. URL: http://dx.doi.org/10.1007/s003359901008, doi:10.1007/s003359901008. This article has 23 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s003359901008)

[5. (GarcíaCorzo2022The) Laura García-Corzo, Isabel Calatayud-Baselga, Lucía Casares-Crespo, Carlos Mora-Martínez, Juan Julián Escribano-Saiz, Rafael Hortigüela, Andrea Asenjo-Martínez, Antonio Jordán-Pla, Stefano Ercoli, Nuria Flames, Victoria López-Alonso, Marçal Vilar, and Helena Mira. The transcription factor lef1 interacts with nfix and switches isoforms during adult hippocampal neural stem cell quiescence. Frontiers in Cell and Developmental Biology, July 2022. URL: http://dx.doi.org/10.3389/fcell.2022.912319, doi:10.3389/fcell.2022.912319. This article has 5 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fcell.2022.912319)

[6. (Yoneda2012Missense) Yuriko Yoneda, Hirotomo Saitsu, Mayumi Touyama, Yoshio Makita, Akie Miyamoto, Keisuke Hamada, Naohiro Kurotaki, Hiroaki Tomita, Kiyomi Nishiyama, Yoshinori Tsurusaki, Hiroshi Doi, Noriko Miyake, Kazuhiro Ogata, Kenji Naritomi, and Naomichi Matsumoto. Missense mutations in the dna-binding/dimerization domain of nfix cause sotos-like features. Journal of Human Genetics, 57(3):207–211, February 2012. URL: http://dx.doi.org/10.1038/jhg.2012.7, doi:10.1038/jhg.2012.7. This article has 52 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/jhg.2012.7)

[7. (Piper2019Nuclear) Michael Piper, Richard Gronostajski, and Graziella Messina. Nuclear factor one x in development and disease. Trends in Cell Biology, 29(1):20–30, January 2019. URL: http://dx.doi.org/10.1016/j.tcb.2018.09.003, doi:10.1016/j.tcb.2018.09.003. This article has 39 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.tcb.2018.09.003)

[8. (Driller2007Nuclear) Katrin Driller, Axel Pagenstecher, Markus Uhl, Heymut Omran, Ansgar Berlis, Albert Gründer, and Albrecht E. Sippel. Nuclear factor i x deficiency causes brain malformation and severe skeletal defects. Molecular and Cellular Biology, 27(10):3855–3867, May 2007. URL: http://dx.doi.org/10.1128/mcb.02293-06, doi:10.1128/mcb.02293-06. This article has 117 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1128/mcb.02293-06)

[9. (Harris2018Neurogenic) Lachlan Harris, Oressia Zalucki, Olivier Clément, James Fraser, Elise Matuzelski, Sabrina Oishi, Tracey J. Harvey, Thomas H. J. Burne, Julian Ik-Tsen Heng, Richard M. Gronostajski, and Michael Piper. Neurogenic differentiation by hippocampal neural stem and progenitor cells is biased by nfix expression. Development, February 2018. URL: http://dx.doi.org/10.1242/dev.155689, doi:10.1242/dev.155689. This article has 29 citations and is from a peer-reviewed journal.](https://doi.org/10.1242/dev.155689)

[10. (Martynoga2013Epigenomic) Ben Martynoga, Juan L. Mateo, Bo Zhou, Jimena Andersen, Angeliki Achimastou, Noelia Urbán, Debbie van den Berg, Dimitra Georgopoulou, Suzana Hadjur, Joachim Wittbrodt, Laurence Ettwiller, Michael Piper, Richard M. Gronostajski, and François Guillemot. Epigenomic enhancer annotation reveals a key role for nfix in neural stem cell quiescence. Genes &amp; Development, 27(16):1769–1786, August 2013. URL: http://dx.doi.org/10.1101/gad.216804.113, doi:10.1101/gad.216804.113. This article has 214 citations.](https://doi.org/10.1101/gad.216804.113)

[11. (Martinez2015Novel) Francisco Martinez, Purificación Marín-Reina, Amparo Sanchis-Calvo, Antonio Perez-Aytés, Silvestre Oltra, Mónica Roselló, Sonia Mayo, Sandra Monfort, Jorge Pantoja, and Carmen Orellana. Novel mutations of nfix gene causing marshall-smith syndrome or sotos-like syndrome: one gene, two phenotypes. Pediatric Research, 78(5):533–539, July 2015. URL: http://dx.doi.org/10.1038/pr.2015.135, doi:10.1038/pr.2015.135. This article has 36 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/pr.2015.135)

[12. (Oishi2019Heterozygosity) Sabrina Oishi, Danyon Harkins, Nyoman D. Kurniawan, Maria Kasherman, Lachlan Harris, Oressia Zalucki, Richard M. Gronostajski, Thomas H.J. Burne, and Michael Piper. Heterozygosity for nuclear factor one x in mice models features of malan syndrome. EBioMedicine, 39:388–400, January 2019. URL: http://dx.doi.org/10.1016/j.ebiom.2018.11.044, doi:10.1016/j.ebiom.2018.11.044. This article has 10 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.ebiom.2018.11.044)

[13. (Malan2010Distinct) Valérie Malan, Diana Rajan, Sophie Thomas, Adam C. Shaw, Hélène Louis dit Picard, Valérie Layet, Marianne Till, Arie van Haeringen, Geert Mortier, Sheela Nampoothiri, Silvija Pušeljić, Laurence Legeai-Mallet, Nigel P. Carter, Michel Vekemans, Arnold Munnich, Raoul C. Hennekam, Laurence Colleaux, and Valérie Cormier-Daire. Distinct effects of allelic nfix mutations on nonsense-mediated mrna decay engender either a sotos-like or a marshall-smith syndrome. The American Journal of Human Genetics, 87(2):189–198, August 2010. URL: http://dx.doi.org/10.1016/j.ajhg.2010.07.001, doi:10.1016/j.ajhg.2010.07.001. This article has 131 citations.](https://doi.org/10.1016/j.ajhg.2010.07.001)

[14. (Klaassens2014Malan) Merel Klaassens, Deborah Morrogh, Elisabeth M Rosser, Fatima Jaffer, Maaike Vreeburg, Levinus A Bok, Tim Segboer, Martine van Belzen, Ros M Quinlivan, Ajith Kumar, Jane A Hurst, and Richard H Scott. Malan syndrome: sotos-like overgrowth with de novo nfix sequence variants and deletions in six new patients and a review of the literature. European Journal of Human Genetics, 23(5):610–615, August 2014. URL: http://dx.doi.org/10.1038/ejhg.2014.162, doi:10.1038/ejhg.2014.162. This article has 47 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/ejhg.2014.162)